Ticker Details
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
IPO Date:	April 2, 1991
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$70.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$4.70 | 1.90%
Avg Daily Range (30 D):	$8.32 | 1.32%
Avg Daily Range (90 D):	$10.23 | 1.45%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	.77M
Avg Daily Volume (90 D):	.64M

Trade Size
Avg Trade Size (Sh.):	59
Avg Trade Size (Sh.) (30 D):	22
Avg Trade Size (Sh.) (90 D):	20

Institutional Trades
Total Institutional Trades:	11,880
Avg Institutional Trade:	$20.14M
Avg Institutional Trade (30 D):	$62.92M
Avg Institutional Trade (90 D):	$56.04M
Avg Institutional Trade Volume:	.05M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$39.84M
Avg Closing Trade (30 D):	$161.77M
Avg Closing Trade (90 D):	$118.12M
Avg Closing Volume:	77.66K

News

Jul 3, 2026 @ 8:40 AM Dupilumab Achieves Record $11.9 Billion in Global ... Source: Researchandmarkets.Com

Jul 2, 2026 @ 10:33 AM Wall Street Thinks This Biotech Stock Can Soar 45%... Source: James Halley

Jun 23, 2026 @ 12:00 PM Questex’s PODD, the Premier Gathering for D... Source: Not Specified

Jun 22, 2026 @ 10:36 PM AbbVie's $10.9 Billion Apogee Deal Will Extend Its... Source: Eric Volkman

Jun 20, 2026 @ 3:02 PM Intellia Therapeutics vs. Omeros: Which Emerging B... Source: Brendan Coffey

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$42.56	$6.99	$8.24
Diluted EPS	$41.05	$6.75	$7.87
Revenue	$14.92B	$3.61B	$3.88B
Gross Profit
Net Income / Loss	$4.42B	$727.2M	$844.6M
Operating Income / Loss	$3.63B	$642.9M	$879.9M
Cost of Revenue
Net Cash Flow	$-122.4M	$-153.1M	$610.6M
PE Ratio